CS logo
small CS logo
Mountainside Hospital

Montclair, New Jersey, United States
Hospital in Glen Ridge, New Jersey
1 Bay Ave, Montclair, NJ 07042
231 Beds

About Mountainside Hospital


Hackensack Meridian Health Mountainside, also known as Mountainside Hospital, is an acute-care hospital located in Montclair, New Jersey, United States. The hospital has 396 beds and serves Northeastern Essex County.
There are 231 beds in Mountainside Hospital.
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
National Cancer Institute (NCI)
6
Rutgers, The State University of New Jersey
2
BioVex Limited
1
ECOG-ACRIN Cancer Research Group
1
GOG Foundation
1
Galera Therapeutics, Inc.
1
Genentech, Inc.
1
Inflammatix
1
University of Medicine and Dentistry of New Jersey
1
Total Rows: 9

Clinical Trials at Mountainside Hospital


During the past decade, Mountainside Hospital conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 10 clinical trials were completed, i.e. on average, 500% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years11111100Started TrialsCompleted Trails2019202000.511.5
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Doxorubicin Hydrochloride, Cisplatin, and Paclitaxel or Carboplatin and Paclitaxel in Treating Patients With Stage III-IV or Recurrent Endometrial Cancer
2003-08-25
2021-01-05
Completed
1,381
Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer
2004-02-01
2012-11-01
Completed
3,397
Ixabepilone in Treating Patients With Metastatic Prostate Cancer
2004-09-01
2011-02-01
Completed
124
Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
2005-08-04
2022-12-01
Active, not recruiting
3,610
A Study Comparing Bevacizumab Therapy With or Without Erlotinib for First-Line Treatment of Non-Small Cell Lung Cancer (ATLAS)
2006-01-01
2014-11-01
Completed
1,145
Cisplatin and Radiation Therapy With or Without Tirapazamine in Treating Patients With Cervical Cancer
2006-02-01
2010-08-01
Terminated
402
A Study of Talimogene Laherparepvec in Stage IIIc and Stage IV Malignant Melanoma
2005-12-01
2009-05-01
Completed
50
Postoperative Chemotherapy With or Without Bevacizumab for Patients With Stage II or III Rectal Cancer
2006-02-17
2019-02-11
Terminated
355

Rows per page:

1–15 of 15

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Mountainside Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 6 trials, followed by "Rutgers, The State University of New Jersey" with 2 trials sponsored, "BioVex Limited" with 1 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 1 trials sponsored and "GOG Foundation" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Mountainside Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 5 trials as a collaborator, "NCIC Clinical Trials Group" with 3 trials as a collaborator, "Cancer and Leukemia Group B" with 2 trials as a collaborator, "Rutgers Cancer Institute of New Jersey" with 2 trials as a collaborator and "SWOG Cancer Research Network" with 2 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.
Created with Highcharts 11.1.0Top Leading SponsorsNational Cancer Institute (NCI): 6National Cancer Institute (NCI): 6Rutgers, The StateUniversity of NewJersey: 2Rutgers, The StateUniversity of NewJersey: 2BioVex Limited: 1BioVex Limited: 1ECOG-ACRIN CancerResearch Group: 1ECOG-ACRIN CancerResearch Group: 1GOG Foundation: 1GOG Foundation: 1Galera Therapeutics, Inc.: 1Galera Therapeutics, Inc.: 1Genentech, Inc.: 1Genentech, Inc.: 1Inflammatix: 1Inflammatix: 1University of Medicineand Dentistry of NewJersey: 1University of Medicineand Dentistry of NewJersey: 1

Created with Highcharts 11.1.0Top CollaboratorsNational Cancer Institute (NCI): 5National Cancer Institute (NCI): 5NCIC Clinical Trials Group: 3NCIC Clinical Trials Group: 3Cancer and LeukemiaGroup B: 2Cancer and LeukemiaGroup B: 2Rutgers Cancer Instituteof New Jersey: 2Rutgers Cancer Instituteof New Jersey: 2SWOG Cancer ResearchNetwork: 2SWOG Cancer ResearchNetwork: 2American College ofSurgeons: 1American College ofSurgeons: 1Eastern CooperativeOncology Group: 1Eastern CooperativeOncology Group: 1Gynecologic Oncology Group: 1Gynecologic Oncology Group: 1NSABP Foundation Inc: 1NSABP Foundation Inc: 1North Central CancerTreatment Group: 1North Central CancerTreatment Group: 1

Clinical Trials Conditions at Mountainside Hospital


According to Clinical.Site data, the most researched conditions in "Mountainside Hospital" are "Adenocarcinoma of the Colon" (1 trials), "Adenocarcinoma of the Prostate" (1 trials), "Adenocarcinoma of the Rectum" (1 trials), "Breast Adenocarcinoma" (1 trials) and "Breast Cancer" (1 trials). Many other conditions were trialed in "Mountainside Hospital" in a lesser frequency.

Clinical Trials Intervention Types at Mountainside Hospital


Most popular intervention types in "Mountainside Hospital" are "Drug" (13 trials), "Other" (4 trials), "Biological" (3 trials), "Diagnostic Test" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.
The name of intervention was led by "Laboratory Biomarker Analysis" (4 trials), "Quality-of-Life Assessment" (3 trials), "bevacizumab" (2 trials), "fluorouracil" (2 trials) and "leucovorin calcium" (2 trials). Other intervention names were less common.

Clinical Trials Genders at Mountainside Hospital


The vast majority of trials in "Mountainside Hospital" are 10 trials for "All" genders, 3 trials for "Female" genders and 2 trials for "Male" genders.

Clinical Trials Status at Mountainside Hospital


Currently, there are NaN active trials in "Mountainside Hospital". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Mountainside Hospital, undefined suspended trials, and 5 terminated clinical trials to date.
Out of the total trials that were conducted in Mountainside Hospital, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 8Phase 3: 8Phase 2: 5Phase 2: 5

Created with Highcharts 11.1.0Trials StatusCompleted: 7Completed: 7Terminated: 5Terminated: 5Active, not recruiting: 2Active, not recruiting: 2Recruiting: 1Recruiting: 1

Departments of Mountainside Hospital


Mountainside Hospital has several departments that took part in Clinical trials: "Mountainside Hospital Cancer Center" - 10 trials
Departments List
Name
City
Trials
Total Rows: 1